A case with familial hypercholesterolemia complicated with severe systemic atherosclerosis intensively treated for more than 30 years
Tetsuo Nishikawa(Yokohama Rosai Hospital), Masa‐aki Kawashiri(Kanazawa University), Masayuki Takamura(Kanazawa University), Mika Mori(Kanazawa University), Kenji Sakata(Kanazawa University), Atsushi Nohara(Kanazawa University), Hirofumi Takemura(Kanazawa University), Kenji Ino(Kanazawa University), Hiroki Kato(Zeria Pharmaceutical (Japan)), Hayato Tada(Kanazawa University), Toshinori Higashikata(Kanazawa University), Shohei Yoshida(Kanazawa University), Satoru Niwa(Kanazawa University), Tamami Nakagawa-Kamiya(Kanazawa University)
Cited by 4
Related Papers
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
|Cell Metabolism|2016|900
Diversification of transcriptional modulation: Large-scale identification and characterization of putative alternative promoters of human genes
|Genome Research|2005|506
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
|Journal of Atherosclerosis and Thrombosis|2018|226
Guidelines for the Management of Familial Hypercholesterolemia
|Journal of Atherosclerosis and Thrombosis|2012|177
S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species
|Cardiovascular Research|2009|143